Showing results (101-110 of 1,011) with videos related to
Sort By:
Pageof 102
Molecular Psychiatry|January 29, 2025
The genetics of neurodegenerative diseases is the genetics of age-related damage clearance failureJohn Hardy, Valentina Escott-PriceEuropean Neurology|March 2, 2022
Charcot's AnglophiliaLéo Coutinho, Olivier Walusinski, Andrew J Lees, et al.Current Treatment Options in Neurology|August 16, 2016
Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment OptionsRuth Lamb, Jonathan D Rohrer, Andrew J Lees, et al.Journal of the History of the Neurosciences|August 1, 2024
'A divine right to photograph': E. Graeme Robertson's (1903-1975) historical motion pictures of National Hospital staff in 1933Nadeem Toodayan, Denis G Robertson, Neil E Anderson, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2006
Punding and dyskinesiasLaura Silveira-Moriyama, Andrew H Evans, Regina Katzenschlager, et al.Neuroscience Letters|March 31, 2004
Failure in heat-shock protein expression in response to UBB+1 protein in progressive supranuclear palsy in humansAndrew D Hope, Tammaryn Lashley, Andrew J Lees, et al.Archives of Medical Research|December 24, 2018
Sir William Osler's 'Influences' for the Successful Physician, A Reappraisal After 126 YearsSergio A Castillo-Torres, Ingrid E Estrada-Bellmann, Andrew J LeesJournal of the Neurological Sciences|August 16, 2011
Clinical aspects of impulsive compulsive behaviours in Parkinson's diseaseAtbin Djamshidian, Bruno B Averbeck, Andrew J Lees, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 17, 2017
PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's diseaseAlastair J Noyce, Lea R'Bibo, Luisa Peress, et al.Journal of Neurology|April 3, 2007
MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effectsDominic C Paviour, Shona L Price, Andrew J Lees, et al.Pageof 102